We are live on ! Find out more
NVO

Novo Nordisk

1,511 hedge funds and large institutions have $33.4B invested in Novo Nordisk in 2023 Q4 according to their latest regulatory filings, with 289 funds opening new positions, 582 increasing their positions, 443 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

390% more first-time investments, than exits

New positions opened: 289 | Existing positions closed: 59

31% more repeat investments, than reductions

Existing positions increased: 582 | Existing positions reduced: 443

21% more capital invested

Capital invested by funds: $27.6B → $33.4B (+$5.86B)

21% more call options, than puts

Call options by funds: $719M | Put options by funds: $596M

16% more funds holding

Funds holding: 1,3071,511 (+204)

13% more funds holding in top 10

Funds holding in top 10: 6270 (+8)

0.57% more ownership

Funds ownership: 8.74%9.31% (+0.57%)

Holders
1,511
Holders Change
+204
Holders Change %
+15.61%
% of All Funds
22.03%
Holding in Top 10
70
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+12.9%
% of All Funds
1.02%
New
289
Increased
582
Reduced
443
Closed
59
Calls
$719M
Puts
$596M
Net Calls
+$123M
Net Calls Change
+$526M
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$326M -$4.09M -41,389 -1%
Natixis Advisors
27
Natixis Advisors
Massachusetts
$316M +$5.47M +55,333 +2%
RJA
28
Raymond James & Associates
Florida
$290M +$12.8M +129,140 +5%
ClearBridge Investments
29
ClearBridge Investments
New York
$239M +$8.82M +89,152 +4%
1832 Asset Management
30
1832 Asset Management
Ontario, Canada
$228M +$26.6M +269,158 +14%
MG
31
Markel Group
Virginia
$222M
SC
32
Saturna Capital
Washington
$220M -$223K -2,250 -0.1%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$184M -$350K -3,535 -0.2%
Stifel Financial
34
Stifel Financial
Missouri
$168M +$9.86M +99,677 +7%
Janus Henderson Group
35
Janus Henderson Group
United Kingdom
$162M +$26M +263,279 +20%
SFM
36
Soros Fund Management
New York
$161M +$2.87M +29,000 +2%
Amundi
37
Amundi
France
$159M +$134M +1,359,388 +1,031%
Lazard Asset Management
38
Lazard Asset Management
New York
$151M -$3.46M -35,020 -2%
FGAM
39
Financial Gravity Asset Management
Texas
$148M +$2.33M +23,511 +9%
Thrivent Financial for Lutherans
40
Thrivent Financial for Lutherans
Minnesota
$145M +$35.6M +359,798 +34%
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$139M -$5.46M -55,181 -4%
Tiger Global Management
42
Tiger Global Management
New York
$131M
American Century Companies
43
American Century Companies
Missouri
$131M +$16.6M +168,126 +15%
Artisan Partners
44
Artisan Partners
Wisconsin
$130M -$31.4M -317,082 -20%
Corient Private Wealth
45
Corient Private Wealth
Florida
$129M +$40.7M +411,907 +49%
Ameriprise
46
Ameriprise
Minnesota
$110M -$879K -8,888 -0.8%
Millennium Management
47
Millennium Management
New York
$102M +$61.8M +624,805 +175%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$100M +$4.37M +44,150 +5%
LPL Financial
49
LPL Financial
California
$97M +$17.4M +176,325 +23%
TIM
50
Thornburg Investment Management
New Mexico
$88.8M -$3.93M -39,691 -4%

NVO Hedge Fund Activity: Q4 2023 in Review

1,511 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2023, worth a combined $33.4B — up 21% from $27.6B a quarter earlier.

Buyers outnumbered sellers: 289 funds opened new NVO positions and 59 closed out — a net gain of 230 holders — while 582 added to existing stakes and 443 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.19B. The largest seller was Renaissance Technologies, cutting an estimated $235M.

  • 1,511 institutional investors held Novo Nordisk (NVO) as of Q4 2023, up from 1,307 in Q3 2023.
  • Funds reported $33.4B of Novo Nordisk stock for Q4 2023, up 21% quarter-over-quarter.
  • 289 funds opened new Novo Nordisk positions in Q4 2023 and 59 closed out, a net change of +230 holders.
  • The largest Novo Nordisk buyer in Q4 2023 was Morgan Stanley, an estimated $1.19B added.
  • The largest Novo Nordisk seller in Q4 2023 was Renaissance Technologies, an estimated $235M sold.

Based on aggregated 13F filings for Q4 2023.